CN115572306A - Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane - Google Patents

Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane Download PDF

Info

Publication number
CN115572306A
CN115572306A CN202211289012.1A CN202211289012A CN115572306A CN 115572306 A CN115572306 A CN 115572306A CN 202211289012 A CN202211289012 A CN 202211289012A CN 115572306 A CN115572306 A CN 115572306A
Authority
CN
China
Prior art keywords
diethyl ester
triethylene glycol
acid diethyl
volume ratio
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211289012.1A
Other languages
Chinese (zh)
Inventor
郑海富
夏勋荣
杨梅
夏炎
李明明
顾加雨
赵莉
金鑫
殷格漫
庄琪逸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Njut Membrane Engineer Design & Research Institute Co ltd
Jiangsu Institute Of Econometrics (jiangsu Energy Measurement Data Center)
Original Assignee
Njut Membrane Engineer Design & Research Institute Co ltd
Jiangsu Institute Of Econometrics (jiangsu Energy Measurement Data Center)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Njut Membrane Engineer Design & Research Institute Co ltd, Jiangsu Institute Of Econometrics (jiangsu Energy Measurement Data Center) filed Critical Njut Membrane Engineer Design & Research Institute Co ltd
Priority to CN202211289012.1A priority Critical patent/CN115572306A/en
Publication of CN115572306A publication Critical patent/CN115572306A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

The invention relates to the technical field of chemical synthesis, in particular to a method for synthesizing silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane. The invention firstly uses ethyl iodoacetate and allyloxy triethylene glycol inN,N-1, 8-diazabicyclo [5.4.0 ] in Dimethylformamide (DMF)]Synthesis of diethyl allyloxytrimethyleneglycolacyliminodiacetate in a series of reactions with undec-7-ene (DBU) as catalyst. This derivative was reacted with chloroperoxybenzoic acid (MCPBA) and triphenylphosphine (Ph) 3 P) are mixed successively in the presence of sodium hydride as a strong base and boron trifluoride etherate (BF) 3• C 2 H 6 O) is used as a catalyst, and the epoxypropyl triethylene glycol acyl iminodiacetic acid diethyl ester is synthesized. Finally, the mixture is mixed with (3-chloropropyl) triethoxysilane under the condition of superbase sodium block, and the target product is prepared by reaction under the catalysis of a phase transfer catalyst benzyltriethylammonium chloride (TEBA). The method of the invention fills the defect that the prior art contains the imidoSynthesis of diethyl diacetate headgroup organosilanes is blank.

Description

一种新型硅烷偶联剂三氧基-三乙氧基-亚胺二乙酸二乙酯有 机硅烷的合成方法A new type of silane coupling agent trioxy-triethoxy-iminodiacetate diethyl ester has Synthesis method of organosilane

技术领域technical field

本发明涉及化学合成技术领域,具体地说是一种新型硅烷偶联剂三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成方法。The invention relates to the technical field of chemical synthesis, in particular to a method for synthesizing a novel silane coupling agent trioxyl-triethoxyl-iminodiacetate diethyl organosilane.

背景技术Background technique

亚氨基二乙酸二乙酯是重要的医药、农药及材料的中间体、例如可以用于制备脑功能药荷拉西坦,同时也被广泛应用于表面活性剂、络合剂、食品添加剂、电镀工业金属表面处理、高分子材料工业、制药等领域。Diethyl iminodiacetate is an important intermediate of medicines, pesticides and materials. For example, it can be used to prepare the brain function drug Joracetam. Industrial metal surface treatment, polymer material industry, pharmaceuticals and other fields.

自然界中,诸如玻璃、石英、陶瓷等有许多无机物都含有Si-O-Si键,所以普遍都缺少有机基团,因而这些化合物都属于无机聚硅氧烷类。然而在在有机硅化学中需要在硅原子上连接机基团,从而形成硅氧烷类化合物,这类有机硅物质既能与无机物中的羟基又能与有机聚合物中的长分子链相互作用,使两种不同性质的材料偶联起来,从而改善生物材料的各种性能。因此,广泛应用在在橡胶、塑料、填充复合材料、环氧封装材料、弹性体、涂料、粘合剂和密封剂等方面。In nature, many inorganic substances such as glass, quartz, and ceramics contain Si-O-Si bonds, so they generally lack organic groups, so these compounds belong to the category of inorganic polysiloxanes. However, in organosilicon chemistry, it is necessary to connect organic groups to silicon atoms to form siloxane compounds, which can interact with both hydroxyl groups in inorganic substances and long molecular chains in organic polymers. Function, so that two materials with different properties are coupled to improve various properties of biomaterials. Therefore, it is widely used in rubber, plastics, filled composite materials, epoxy encapsulation materials, elastomers, coatings, adhesives and sealants, etc.

三乙基硅基广泛存在于有机化合物中,并且在有机合成中有重要的应用。硅杂环化合物因其独特的理化性质而被广泛地应用于有机合成化学、材料化学和药物化学中。因此,将含有三乙基硅基基团的有机化合物直接用于医药、农药等中间体合成的研究具有重要的意义。硅基化反应在化学合成法中能够保护特定官能团以降低沸点,增加化合物的挥发性,这一特性在医药、农药等领域作为中间体化合物中有重要的应用前景。Triethylsilyl exists widely in organic compounds and has important applications in organic synthesis. Silicon heterocyclic compounds are widely used in organic synthesis chemistry, materials chemistry and medicinal chemistry because of their unique physical and chemical properties. Therefore, it is of great significance to directly use organic compounds containing triethylsilyl groups in the synthesis of intermediates such as medicines and pesticides. The silylation reaction can protect specific functional groups in the chemical synthesis method to reduce the boiling point and increase the volatility of the compound. This feature has an important application prospect as an intermediate compound in the fields of medicine and pesticides.

研究表明,聚乙二醇(PEG)头基可以减少生物体内蛋白和亚氨基二乙酸二乙酯相互作用,所以在亚氨基二乙酸二乙酯上连接有PEG头基,可以降低生物药剂在进入靶点前的非特异性吸附,提高生物药剂的靶向性。Studies have shown that polyethylene glycol (PEG) head group can reduce the interaction between protein and diethyl iminodiacetate in the organism, so the PEG headgroup connected to diethyl iminodiacetate can reduce the entry of biological agents Non-specific adsorption in front of the target improves the targeting of biopharmaceuticals.

目前以亚氨基二乙酸二乙酯为指引头基,以聚乙二醇为间链、三乙基硅基为尾标的有机硅化合物未见相关合成报道。At present, there is no relevant synthesis report on organosilicon compounds with diethyl iminodiacetate as the head group, polyethylene glycol as the intermediate chain, and triethylsilyl as the tail.

发明内容Contents of the invention

本发明的目的是解决以亚氨基二乙酸二乙酯为指引头基,以聚乙二醇为间链、三乙基硅基为尾标的有机硅化合物的合成问题,提供一种三氧基-三乙氧基-亚胺二乙酸二乙酯硅烷的合成方法,解决在无机物质和有机物质的界面之间架起“分子桥”问题,对于实现在生物医药靶向识别和控释体系中的作用具有重要意义。The purpose of the present invention is to solve the synthetic problem of the organosilicon compound that takes diethyl iminodiacetate as the index head group, polyethylene glycol as the chain and triethylsilyl as the tail, and provides a trioxyl- The synthesis method of triethoxy-iminodiacetate diethyl silane solves the problem of building a "molecular bridge" between the interface of inorganic substances and organic substances, and plays a role in realizing the target recognition and controlled release system of biomedicine is of great significance.

通过上述合成的有机硅化合物,可在无机物质和有机物质的界面之间架起“分子桥”,把两种性质完全不同的材料连接在一起。三乙基硅基、亚氨基二乙酸二乙酯和以聚乙二醇的有机官能团的反应基团可以决定此化合物在生物医药、农药靶向识别和控释体系中所起的靶点作用。Through the organosilicon compound synthesized above, a "molecular bridge" can be built between the interface of inorganic substances and organic substances, and two materials with completely different properties can be connected together. The reactive groups of triethylsilyl group, diethyl iminodiacetate and polyethylene glycol organic functional group can determine the target function of this compound in biomedicine, pesticide targeted recognition and controlled release system.

三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷具有活性优异,常温下结构稳定,立体选择性好,形成的偶联体系稳定性高等诸多优点。该合成方法可用于合成系列硅烷基链、可变聚乙二醇间链等硅烷偶联剂,在有机硅化合物合成研究领域有重要的作用。因此,研究三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成方法,将填补该类有机硅化合物通过无机硅连接技术探究无机物质和有机物质的界面间“分子桥”作用,为医药和农药领域精准给药开辟新的研究应用途径。Trioxy-triethoxy-iminodiacetate diethyl organosilane has many advantages such as excellent activity, stable structure at room temperature, good stereoselectivity, and high stability of the formed coupling system. The synthesis method can be used to synthesize a series of silane coupling agents such as silyl chains and variable polyethylene glycol chains, and plays an important role in the field of organosilicon compound synthesis research. Therefore, the study of the synthesis method of trioxy-triethoxy-iminodiacetate diethyl organosilane will fill in the "molecular bridge" between the interface of inorganic substances and organic substances through the connection technology of inorganic silicon compounds. It will open up a new research and application path for precise drug delivery in the field of medicine and pesticides.

本发明是通过下述技术方案实现的:The present invention is achieved through the following technical solutions:

碘乙酸乙酯与烯丙氧基三甘醇在N,N-二甲基甲酰胺(DMF)中以1,8-二氮杂双环[5.4.0]十一碳-7-烯(DBU)作为催化剂的系列反应中合成烯丙氧基三甘醇酰基亚氨二乙酸二乙酯。此衍生物与氯过氧苯甲酸(MCPBA)和三苯基磷(Ph3P)相继混合,在以氢化钠为强碱条件,以三氟化硼合乙醚(BFC2H6O)为催化剂,合成得到环氧丙基三甘醇酰基亚氨二乙酸二乙酯。最后在超强碱钠块条件下与(3-氯丙基)三乙氧基硅烷混合,在相转移催化剂苄基三乙基氯化铵(TEBA)催化下反应制得目标产物三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷。本发明制备的三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷结构式如下所示:Ethyl iodoacetate and allyloxytriethylene glycol in N,N-dimethylformamide (DMF) as 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) Synthesis of diethyl allyloxytriglycolyl iminodiacetate in a series of reactions as a catalyst. This derivative is mixed with chloroperoxybenzoic acid (MCPBA) and triphenylphosphine (Ph 3 P) successively, under the condition of sodium hydride as a strong base, boron trifluoride diethyl ether (BF 3 · C 2 H 6 O ) as a catalyst, synthesized to obtain diethyl glycidyl triethylene glycol acyl iminodiacetate. Finally, it is mixed with (3-chloropropyl) triethoxysilane under super alkali sodium block conditions, and the target product trioxy- Triethoxy-diethyliminodiacetate organosilane. The trioxy-triethoxy-iminodiacetate diethyl organosilane structural formula prepared by the present invention is as follows:

Figure BDA0003900701560000021
Figure BDA0003900701560000021

所述的三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成方法,包括如下步骤:The synthetic method of described trioxy-triethoxy-iminodiacetate diethyl organosilane comprises the steps:

1)烯丙氧基三甘醇TG-Ally的合成1) Synthesis of allyloxytriethylene glycol TG-Ally

三甘醇溶解在干燥的四氢呋喃(THF)中,室温下搅拌30min后加入纯钠快速搅拌1h,滴加烯丙基溴,继续反应6h;减压蒸馏后的残留物用二氯甲烷溶解,用饱和氯化钠(NaCl)溶液洗涤,无水硫酸镁干燥,过滤浓缩后柱层析提纯;Dissolve triethylene glycol in dry tetrahydrofuran (THF), stir at room temperature for 30 minutes, add pure sodium and stir rapidly for 1 hour, add allyl bromide dropwise, and continue the reaction for 6 hours; the residue after vacuum distillation is dissolved in dichloromethane, and Wash with saturated sodium chloride (NaCl) solution, dry over anhydrous magnesium sulfate, filter and concentrate, and purify by column chromatography;

2)烯丙氧基三甘醇酰基亚氨二乙酸二乙酯的合成2) Synthesis of allyloxy triglycolic iminodiacetic acid diethyl ester

碘乙酸乙酯和TG-Ally混合后溶解在干燥的DMF中,0℃下搅拌1~2h(优选1.5h),快速加入催化剂量的DBU,常温下连续搅拌24h后,加入95%乙醇溶液解多余DBU,用饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤浓缩柱层析,洗脱剂为乙酸乙酯/石油醚。Mix ethyl iodoacetate and TG-Ally and dissolve in dry DMF, stir at 0°C for 1-2h (preferably 1.5h), quickly add a catalytic amount of DBU, stir continuously at room temperature for 24h, then add 95% ethanol solution to decompose Excess DBU was washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered and concentrated by column chromatography, and the eluent was ethyl acetate/petroleum ether.

3)环氧丙基三甘醇酰基亚氨二乙酸二乙酯的合成3) Synthesis of Epoxypropyl Triethylene Glycoyl Iminodiacetate Diethyl Ester

烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与Ph3P和MCPBA混合后溶于干燥二氯甲烷中,随后加入适量氢化钠粉末,缓慢加热至30℃~50℃(优选40℃),快速搅拌30min,逐滴快速加入BFC2H6O,滴加完毕后在室温下连续搅拌30h,反应产物在冰水混合物中冷却至0℃后过滤;将浓缩后的滤液利用混合有机溶剂萃取,有机相通过减压蒸馏。Diethyl allyloxytriglycolyl iminodiacetate is mixed with Ph 3 P and MCPBA and dissolved in dry dichloromethane, then an appropriate amount of sodium hydride powder is added, and slowly heated to 30°C-50°C (preferably 40°C ), stirred rapidly for 30min, quickly added BF 3 · C 2 H 6 O dropwise, and stirred continuously at room temperature for 30h after the dropwise addition, and filtered the reaction product after cooling to 0°C in an ice-water mixture; the concentrated filtrate was used Mixed organic solvents were extracted, and the organic phase was distilled under reduced pressure.

4)三氧基-三乙氧基-亚胺二乙酸二乙酯硅烷的合成4) Synthesis of trioxy-triethoxy-iminodiacetate diethyl silane

环氧丙基三甘醇酰基亚氨二乙酸二乙酯与(3-氯丙基)三乙氧基硅烷溶解在无水DMF中,50℃~80℃(优选60℃)下搅拌2h后,加入催化剂量苄基三乙基氯化铵(TEBA),持续搅拌12h。反应物用饱和碳酸氢钠溶液洗涤,有机相减压浓缩后过滤、浓缩后经柱层析分离,放置冷冻室内3h,得到白色固体。Diethyl glycidyl triglycolyl iminodiacetate and (3-chloropropyl) triethoxysilane were dissolved in anhydrous DMF, and stirred at 50°C to 80°C (preferably 60°C) for 2 hours, A catalytic amount of benzyltriethylammonium chloride (TEBA) was added and stirring continued for 12h. The reactant was washed with saturated sodium bicarbonate solution, the organic phase was concentrated under reduced pressure, filtered, concentrated, separated by column chromatography, and placed in a freezer for 3 hours to obtain a white solid.

进一步地,所述的步骤1)中,Further, in the described step 1),

三甘醇与烯丙基溴的体积比1mL:1.3-2mL;优选1mL:1.5mL。The volume ratio of triethylene glycol to allyl bromide 1 mL: 1.3-2 mL; preferably 1 mL: 1.5 mL.

钠块与三甘醇的质量体积比为1g:2-3mL;优选1g:2.8mL;The mass volume ratio of sodium block to triethylene glycol is 1g: 2-3mL; preferably 1g: 2.8mL;

THF与三甘醇的体积比为3-3.5mL:1mL;优选3mL:1mL。The volume ratio of THF to triethylene glycol is 3-3.5mL: 1mL; preferably 3mL: 1mL.

柱层析中,采用硅胶、EtOAc和EtOAc,其中EtOAc和EtOAc的体积比v/v为1:1。In column chromatography, silica gel, EtOAc and EtOAc are used, wherein the volume ratio v/v of EtOAc and EtOAc is 1:1.

进一步地,所述的步骤2)中,Further, in the described step 2),

碘乙酸乙酯和TG-Ally的质量比1g:2-3g;优选1g:2.5g。The mass ratio of ethyl iodoacetate to TG-Ally is 1g:2-3g; preferably 1g:2.5g.

溶剂DMF必须是无水的;The solvent DMF must be anhydrous;

DMF与碘乙酸乙酯的体积质量比为1mL:0.02-0.05g;优选1mL:0.05g;The volume-to-mass ratio of DMF to ethyl iodoacetate is 1 mL: 0.02-0.05 g; preferably 1 mL: 0.05 g;

DBU与TG-Allyl的体积质量比为1μL:0.5g-1.30g;优选1μL:1.25g;The volume-to-mass ratio of DBU to TG-Allyl is 1 μL: 0.5g-1.30g; preferably 1 μL: 1.25g;

95%乙醇溶液与DBU的体积比为1μL:1μL;The volume ratio of 95% ethanol solution to DBU is 1 μL: 1 μL;

柱层析中,采用硅胶、EtOAc和Petroleum,其中EtOAc和Petroleum的体积比v/v为1:2。In column chromatography, silica gel, EtOAc and Petroleum are used, wherein the volume ratio v/v of EtOAc and Petroleum is 1:2.

进一步地,所述的步骤3)中,Further, in the described step 3),

烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与MCPBA质量比为1g:0.5-1g,优选1g:1g。The mass ratio of allyloxytriglycolyl iminodiacetate to MCPBA is 1g:0.5-1g, preferably 1g:1g.

烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与Ph3P质量比为1g:1.5-2g,优选1g:2g。The mass ratio of allyloxytriglycolyl iminodiacetic acid diethyl ester to Ph 3 P is 1g:1.5-2g, preferably 1g:2g.

萃取滤液的混合有机溶剂为乙醚/乙酸乙酯,体积比v/v为1:1。The mixed organic solvent for extracting the filtrate is diethyl ether/ethyl acetate, and the volume ratio v/v is 1:1.

进一步地,所述的步骤4)中,Further, in the described step 4),

环氧丙基三甘醇酰基亚氨二乙酸二乙酯与(3-氯丙基)三乙氧基硅烷的体积比为15:1。The volume ratio of diethyl glycidyl triglycolyl iminodiacetate to (3-chloropropyl)triethoxysilane is 15:1.

DMF与环氧丙基三甘醇酰基亚氨二乙酸二乙酯的体积比为4-4.5mL:3mL;优选4mL:3mLThe volume ratio of DMF to diethyl glycidyl triglycolyl iminodiacetate is 4-4.5mL: 3mL; preferably 4mL: 3mL

(3-氯丙基)三乙氧基硅烷与TEBA体积质量比为1mL:0.1-0.3g,优选1mL:0.2g。The volume/mass ratio of (3-chloropropyl)triethoxysilane to TEBA is 1 mL: 0.1-0.3 g, preferably 1 mL: 0.2 g.

与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

1)本发明合成三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷是制备硅树脂固胰酶载体的重要原料,可使固化酶不溶于水,未失活的固相酶经过滤后还可继续使用,不仅提高了生物酶的利用率,还能减少环境污染和原料浪费,该合成方法填补了现有技术中有机硅中含亚氨基二乙酸二乙酯的偶联剂化合物合成空白。1) The synthesis of trioxy-triethoxy-iminodiacetate diethyl organosilane of the present invention is an important raw material for the preparation of silicone resin-solidified trypsin carrier, which can make the solidified enzyme insoluble in water and not inactivated solid-phase enzyme It can be used continuously after filtration, which not only improves the utilization rate of biological enzymes, but also reduces environmental pollution and waste of raw materials. This synthesis method fills the coupling agent containing diethyl iminodiacetate in organosilicon in the prior art. Compound synthesis blank.

2)本发明的方法步骤少、操作简便效率高,所需原料及催化剂较常规,低毒或无毒,后续处理简单易回收,产品收率高,突破生物医药类有机硅类化合物合成方法复杂、复杂繁琐且产率较低的限制。2) The method of the present invention has few steps, simple operation and high efficiency, relatively conventional raw materials and catalysts, low toxicity or non-toxicity, simple and easy recovery in follow-up treatment, high product yield, and a breakthrough in the synthesis method of biomedical organosilicon compounds. , complex and cumbersome and low yield limitations.

附图说明Description of drawings

图1为实施例1制备的最终产物的核磁共振检测图谱。Fig. 1 is the NMR detection spectrum of the final product prepared in Example 1.

具体实施方式detailed description

为了使本发明的目的、技术方案及优点更加清晰明了,以下结合附图及实施例,对本发明进行进一步详细说明,显然,所描述的实施例仅是本发明一部分实施例,而不是全部的实施例。In order to make the purpose, technical solutions and advantages of the present invention clearer, the present invention will be described in further detail below in conjunction with the accompanying drawings and embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. example.

实施例1Example 1

(1)烯丙氧基三甘醇TG-Ally的合成(1) Synthesis of allyloxytriethylene glycol TG-Ally

10mL三甘醇溶解在30mL干燥的THF中,室温下搅拌30min后加入3.5g纯钠快速搅拌1h,滴加15mL烯丙基溴,继续反应6h。减压蒸馏后的残留物用30mL二氯甲烷溶解,用饱和NaCl溶液洗涤,无水硫酸镁干燥,过滤浓缩后柱层析提纯得到无色油状产物4g,产率80%。Dissolve 10 mL of triethylene glycol in 30 mL of dry THF, stir at room temperature for 30 min, add 3.5 g of pure sodium and stir rapidly for 1 h, add dropwise 15 mL of allyl bromide, and continue the reaction for 6 h. The residue after vacuum distillation was dissolved in 30 mL of dichloromethane, washed with saturated NaCl solution, dried over anhydrous magnesium sulfate, filtered and concentrated, and purified by column chromatography to obtain 4 g of a colorless oily product with a yield of 80%.

柱层析中,采用硅胶、EtOAc和EtOAc,其中EtOAc和EtOAc的体积比v/v为1:1。In column chromatography, silica gel, EtOAc and EtOAc are used, wherein the volume ratio v/v of EtOAc and EtOAc is 1:1.

(2)烯丙氧基三甘醇酰基亚氨二乙酸二乙酯的合成(2) Synthesis of allyloxy triglycolic iminodiacetic acid diethyl ester

0.5g碘乙酸乙酯和1.25g TG-Ally混合后溶解在10mL干燥的无水DMF中,0℃下搅拌1.5h,快速滴加1μL DBU,连续搅拌24h后,加入1μL 95%乙醇溶分解多余DBU,用饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤浓缩柱层析得到无色粘稠状产物0.4g,产率为75%。Mix 0.5g of ethyl iodoacetate and 1.25g of TG-Ally and dissolve in 10mL of dry anhydrous DMF, stir at 0°C for 1.5h, quickly add 1μL of DBU dropwise, continue stirring for 24h, add 1μL of 95% ethanol to dissolve excess DBU, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered and concentrated column chromatography gave 0.4 g of a colorless viscous product with a yield of 75%.

柱层析中,采用硅胶、EtOAc和Petroleum,其中EtOAc和Petroleum的体积比v/v为1:2。In column chromatography, silica gel, EtOAc and Petroleum are used, wherein the volume ratio v/v of EtOAc and Petroleum is 1:2.

(3)环氧丙基三甘醇酰基亚氨二乙酸二乙酯的合成(3) Synthesis of Epoxypropyl Triglycolyl Iminodiacetate Diethyl Ester

5g的烯丙氧基三甘醇酰基亚氨二乙酸二乙酯与5g MCPBA和10gPh3P先后混合后溶于30ml的二氯甲烷中,将0.5g氢化钠粉末迅速加入溶液中,缓慢加热至40℃,快速搅拌30min,然后滴加50μL BFC2H6O,滴加完毕后在室温下连续搅拌30h。利用冰水混合物冷却至0℃后过滤,将浓缩后的滤液与20ml蒸馏水混合,利用乙醚/乙酸乙酯混合溶剂(v/v=1:1)萃取。含水相通过减压蒸馏获得透明固体产物3g,产率为80%。5g of allyloxy triglycolyl iminodiacetic acid diethyl ester mixed with 5g MCPBA and 10gPh 3 P successively and dissolved in 30ml of dichloromethane, 0.5g of sodium hydride powder was quickly added to the solution, slowly heated to Stir rapidly at 40°C for 30 min, then add 50 μL of BF 3 · C 2 H 6 O dropwise, and continue stirring at room temperature for 30 h after the dropwise addition. After cooling to 0° C. with ice-water mixture, filter, mix the concentrated filtrate with 20 ml of distilled water, and extract with diethyl ether/ethyl acetate mixed solvent (v/v=1:1). The aqueous phase was distilled under reduced pressure to obtain 3 g of a transparent solid product with a yield of 80%.

(4)三氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成(4) Synthesis of trioxy-triethoxy-iminodiacetate diethyl organosilane

7.5ml环氧丙基三甘醇酰基亚氨二乙酸二乙酯与0.5ml(3-氯丙基)三乙氧基硅烷依次溶解在10ml无水DMF中,60℃下搅拌2h后,缓慢加入0.1g的TEBA,持续搅拌12h,反应物用饱和碳酸氢钠溶液洗涤,有机相减压浓缩后过滤,浓缩后经柱层析分离,放置冷冻室内3h,得到白色固体2g。产率为70%。7.5ml of diethyl epoxypropyl triglycolyl iminodiacetate and 0.5ml of (3-chloropropyl)triethoxysilane were dissolved in 10ml of anhydrous DMF in turn, stirred at 60°C for 2h, then slowly added 0.1 g of TEBA was continuously stirred for 12 hours, the reactant was washed with saturated sodium bicarbonate solution, the organic phase was concentrated under reduced pressure and then filtered. After concentration, it was separated by column chromatography and placed in a freezer for 3 hours to obtain 2 g of white solid. The yield was 70%.

1H NMR(500MHz,CDCl3):δ4.44–4.51(s,2H;H-2);4.08–4.18(d,J=12.2Hz,4H;H-1);3.78–3.88(m,2H;2CH2,ethoxy);3.32–3.40(m,2H;CH,acetyl),1.50–1.51(m,4H;2OCH2),1.48(m,4H;OCH2CH2)1.26–1.31(brs,12H;CH3),1.18–1.23(t,3J=6.8Hz,9H;CH3);0.56–0.60(t,3J=6.05and 6.8Hz,2H;CH2). 1 H NMR (500MHz, CDCl 3 ): δ4.44–4.51 (s, 2H; H-2); 4.08–4.18 (d, J=12.2Hz, 4H; H-1); 3.78–3.88 (m, 2H ; 2CH2, ethoxy); 3.32–3.40 (m, 2H; CH, acetyl), 1.50–1.51 (m, 4H; 2OCH2), 1.48 (m, 4H; OCH2CH2), 1.26–1.31 (brs, 12H; CH3), 1.18 –1.23(t,3J=6.8Hz,9H;CH3); 0.56–0.60(t,3J=6.05and 6.8Hz,2H;CH2).

柱层析中,采用硅胶、EtOAc和CH3OH,其中EtOAc和CH3OH的体积比v/v为1:1,Rf=0.48In column chromatography, silica gel, EtOAc and CH 3 OH are used, wherein the volume ratio v/v of EtOAc and CH 3 OH is 1:1, R f =0.48

从图1和上述数据结果,可以看出:依据本发明的合成方法获得的最终产物符合目标物质特征。From Fig. 1 and the above data results, it can be seen that the final product obtained according to the synthesis method of the present invention meets the characteristics of the target substance.

应用例1六氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成Application example 1 Synthesis of hexaoxy-triethoxy-iminodiacetate diethyl organosilane

Figure BDA0003900701560000061
Figure BDA0003900701560000061

(1)烯丙氧基聚六甘醇的合成(1) Synthesis of allyloxy polyhexaethylene glycol

10mL聚六甘醇溶解在30mL干燥的THF中,室温下搅拌60min后加入3.5g纯钠快速搅拌1h,滴加15mL烯丙基溴,继续反应6h。减压蒸馏后的残留物用30mL二氯甲烷溶解,用饱和NaCl溶液洗涤,无水硫酸镁干燥,过滤浓缩后重结晶提纯得到无色固体产物3g,产率70%。Dissolve 10mL of polyhexaethylene glycol in 30mL of dry THF, stir at room temperature for 60min, add 3.5g of pure sodium and stir rapidly for 1h, add dropwise 15mL of allyl bromide, and continue the reaction for 6h. The residue after vacuum distillation was dissolved in 30 mL of dichloromethane, washed with saturated NaCl solution, dried over anhydrous magnesium sulfate, concentrated by filtration and purified by recrystallization to obtain 3 g of a colorless solid product with a yield of 70%.

重结晶溶剂:石油醚(30-60℃)Recrystallization solvent: petroleum ether (30-60°C)

(2)烯丙氧基聚六甘醇酰基亚氨二乙酸二乙酯的合成(2) Synthesis of allyloxy polyhexaethylene glycol acyl iminodiacetate diethyl

0.5g碘乙酸乙酯和1.25g烯丙氧基聚六甘醇混合后溶解在10mL干燥的DMF中,室温搅拌30min,快速滴加

Figure BDA0003900701560000062
DBU,连续搅拌24h后,加入
Figure BDA0003900701560000063
95%乙醇溶分解多余DBU,用饱和NaCl溶液洗涤,无水Na2SO4干燥,过滤浓缩柱层析得到无色针状产物0.5g,产率为80%。Mix 0.5g of ethyl iodoacetate and 1.25g of allyloxy polyhexaethylene glycol, dissolve in 10mL of dry DMF, stir at room temperature for 30min, and add dropwise quickly
Figure BDA0003900701560000062
DBU, after continuous stirring for 24h, add
Figure BDA0003900701560000063
The excess DBU was dissolved in 95% ethanol, washed with saturated NaCl solution, dried over anhydrous Na 2 SO 4 , filtered and concentrated column chromatography to obtain 0.5 g of a colorless needle product with a yield of 80%.

柱层析中,采用硅胶、EtOAc和Petroleum,其中EtOAc和Petroleum的体积比v/v为1:1。In column chromatography, silica gel, EtOAc and Petroleum are used, wherein the volume ratio v/v of EtOAc and Petroleum is 1:1.

(3)环氧丙基聚六甘醇酰基亚氨二乙酸二乙酯的合成(3) Synthesis of glycidyl polyhexaethylene glycol acyl iminodiacetate diethyl

5g的烯丙氧基聚六甘醇酰基亚氨二乙酸二乙酯与5g MCPBA和10gPh3P先后混合后溶于30ml的二氯甲烷中,将0.5g氢化钠粉末迅速加入溶液中,缓慢加热至40℃,快速搅拌30min,然后滴加50μL BFC2H6O,滴加完毕后在室温下连续搅拌30h。利用冰水混合物冷却至0℃后过滤,将浓缩后的滤液与20ml蒸馏水混合,利用乙醚/乙酸乙酯混合溶剂(v/v=1:1)萃取。含水相通过减压蒸馏获得片状白色固体产物2g,产率为60%。5g of allyloxy polyhexaethylene glycol acyl iminodiacetic acid diethyl acetate, 5g of MCPBA and 10g of Ph 3 P were mixed successively and dissolved in 30ml of dichloromethane, 0.5g of sodium hydride powder was quickly added to the solution, and slowly heated to 40°C, stirred rapidly for 30 min, then added 50 μL of BF 3 · C 2 H 6 O dropwise, and stirred continuously at room temperature for 30 h after the dropwise addition. After cooling to 0° C. with ice-water mixture, filter, mix the concentrated filtrate with 20 ml of distilled water, and extract with diethyl ether/ethyl acetate mixed solvent (v/v=1:1). The aqueous phase was distilled under reduced pressure to obtain 2 g of a flaky white solid product with a yield of 60%.

(4)六氧基-三乙氧基-亚胺二乙酸二乙酯有机硅烷的合成(4) Synthesis of hexaoxy-triethoxy-iminodiacetate diethyl organosilane

7.5ml环氧丙基聚六甘醇酰基亚氨二乙酸二乙酯与0.5ml(3-氯丙基)三乙氧基硅烷依次溶解在10ml无水DMF中,60℃下搅拌2h后,缓慢加入0.1g的TEBA,持续搅拌12h,反应物用饱和碳酸氢钠溶液洗涤,有机相减压浓缩后过滤,浓缩后经柱层析分离,放置冷冻室内3h,得到白色固体0.5g。产率为60%。Dissolve 7.5ml of glycidyl polyhexaglycolyl iminodiacetic acid diethyl ester and 0.5ml (3-chloropropyl)triethoxysilane in 10ml of anhydrous DMF in turn, stir at 60°C for 2h, slowly Add 0.1 g of TEBA, continue to stir for 12 h, wash the reactant with saturated sodium bicarbonate solution, concentrate the organic phase under reduced pressure, and filter it. After concentration, it is separated by column chromatography and placed in a freezer for 3 h to obtain 0.5 g of a white solid. The yield was 60%.

1H NMR(500MHz,CDCl3):δ4.50(s,8H;H-2),4.40(12H;H-1),4.13(d,J=12.2Hz,4H;H-1),3.80–3.83(m,2H;2CH2,ethoxy),3.38–3.40(m,2H;CH,acetyl),1(m,4H;2OCH2),1.50–1.53(m,4H;OCH2CH2),1.19–1.22(brs,12H;CH3),0.50(t,3J=6.05and 6.8Hz,2H;CH2).1.20–1.21(t,3J=6.8Hz,9H;CH3) 1 H NMR (500MHz, CDCl 3 ): δ4.50(s, 8H; H-2), 4.40(12H; H-1), 4.13(d, J=12.2Hz, 4H; H-1), 3.80– 3.83 (m, 2H; 2CH 2 , ethoxy), 3.38–3.40 (m, 2H; CH, acetyl), 1 (m, 4H; 2OCH 2 ), 1.50–1.53 (m, 4H; OCH 2 CH 2 ), 1.19 –1.22(brs,12H; CH 3 ), 0.50(t, 3 J=6.05 and 6.8Hz,2H; CH 2 ).1.20–1.21(t, 3 J=6.8Hz,9H; CH 3 )

柱层析中,采用硅胶、EtOAc和CH3OH,其中EtOAc和CH3OH的体积比v/v为1:1,Rf=0.53.In column chromatography, silica gel, EtOAc and CH 3 OH are used, wherein the volume ratio v/v of EtOAc and CH 3 OH is 1:1, R f =0.53.

以上仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效变换,或直接或间接运用在其它相关的技术领域,均同理包括在本发明的专利保护范围内。The above are only examples of the present invention, and are not intended to limit the patent scope of the present invention. All equivalent transformations made using the content of the description of the present invention, or directly or indirectly used in other related technical fields, are equally included in the scope of the present invention. within the scope of patent protection.

Claims (10)

1. A synthesis method of trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane is characterized in that,
the structural formula of the triethoxy-diethyl iminodiacetate organosilane is shown as follows:
Figure FDA0003900701550000011
the synthesis method comprises the following steps:
1) Synthesis of allyloxytrimethylglycol TG-aly
Dissolving triethylene glycol in dry Tetrahydrofuran (THF), stirring at room temperature for 30min, adding pure sodium, quickly stirring for 1h, dropwise adding allyl bromide, and continuously reacting for 6h; dissolving the residue after reduced pressure distillation with dichloromethane, washing with saturated sodium chloride NaCl solution, drying with anhydrous magnesium sulfate, filtering, concentrating, and purifying by column chromatography;
2) Synthesis of allyloxytrimethyleneglycol acyliminodiacetic acid diethyl ester
Mixing ethyl iodoacetate and TG-aly, dissolving in dry DMF, stirring at 0 deg.C for 1-2 hr, quickly adding catalytic amount of DBU, stirring at normal temperature for 24 hr, adding 95% ethanol solution to dissolve excessive DBU, washing with saturated NaCl solution, and adding anhydrous Na 2 SO 4 Drying, filtering, concentrating, and performing column chromatography with ethyl acetate/petroleum ether as eluent;
3) Synthesis of epoxypropyl triethylene glycol acyl imino diethyl diacetate
Allyloxytrimethyleneglycol acyliminodiacetic acid diethyl ester with Ph 3 Mixing P and MCPBA, dissolving in dry dichloromethane, adding appropriate amount of sodium hydride powder, slowly heating to 30-50 deg.C, rapidly stirring for 30min, and rapidly adding BF dropwise 3 ·C 2 H 6 O, continuously stirring for 30 hours at room temperature after the dropwise addition is finished, cooling a reaction product in an ice-water mixture to 0 ℃, and filtering; extracting the concentrated filtrate with mixed organic solvent, and distilling the organic phase under reduced pressure;
4) Synthesis of triethoxy-iminodiacetic acid diethyl ester organosilane
Dissolving epoxypropyl triethylene glycol acyl iminodiacetic acid diethyl ester and (3-chloropropyl) triethoxysilane in anhydrous DMF, stirring at 50-80 deg.C for 2h, adding benzyl triethyl ammonium chloride (TEBA) as catalyst, and continuously stirring for 12h; washing the reactant with saturated sodium bicarbonate solution, concentrating the organic phase under reduced pressure, filtering, concentrating, separating by column chromatography, and standing in a freezing chamber for 3h to obtain white solid.
2. The method according to claim 1, wherein in step 1),
volume ratio of triethylene glycol to allyl bromide 1mL:1.3-2mL;
the mass-to-volume ratio of the sodium lumps to the triethylene glycol is 1g:2-3mL;
the volume ratio of THF to triethylene glycol was 3-3.5mL:1mL;
in column chromatography, silica gel and Et are used 2 O and EtOAc, wherein Et 2 The volume ratio v/v of O and EtOAc is 1.
3. The method according to claim 1, wherein in step 2),
the mass ratio of ethyl iodoacetate to TG-aly is 1g:2-3g;
the solvent DMF must be anhydrous;
the volume-mass ratio of DMF to iodoethyl acetate is 1mL:0.02-0.05g;
the volume mass ratio of DBU to TG-aly is 1 mu L:0.5g to 1.30g;
the volume ratio of the 95% ethanol solution to the DBU is 1 mu L:1 mu L of the solution;
in column chromatography, silica gel, etOAc and Petroleum are used, wherein the volume ratio v/v of EtOAc and Petroleum is 1.
4. The method according to claim 1, wherein, in the step 3),
the mass ratio of allyloxytrimethyleneglycol acyl iminodiacetic acid diethyl ester to MCPBA is 1g:0.5-1g;
allyloxy groupTriethylene glycol acyl iminodiacetic acid diethyl ester and Ph 3 The mass ratio of P is 1g:1.5-2g;
the mixed organic solvent of the extraction filtrate is diethyl ether/ethyl acetate, and the volume ratio v/v is 1.
5. The method according to claim 1, wherein, in the step 4),
the volume ratio of the glycidyl triethylene glycol acyl iminodiacetic acid diethyl ester to the (3-chloropropyl) triethoxysilane is 15:1;
the volume ratio of DMF to diethyl epoxypropyltriglycol acyliminodiacetate is 4-4.5mL:3mL;
the volume-to-mass ratio of (3-chloropropyl) triethoxysilane to TEBA is 1mL:0.1-0.3g.
6. The method of claim 1,
in the step 2) of synthesizing allyloxytrimethyleneglycol acyl diethyl iminodiacetate, iodoethyl acetate and allyloxytrimethylene glycol are mixed and then dissolved in dry DMF, and the mixture is stirred for 1.5 hours at the temperature of 0 ℃;
in the step 3), during the synthesis of the glycidyl triethylene glycol acyl diethyl iminodiacetate, adding a proper amount of sodium hydride powder, and slowly heating to 40 ℃;
in the step 4) of synthesizing the triethoxy-iminodiacetic acid diethyl ester organosilane, dissolving epoxypropyl triethylene glycol acyl iminodiacetic acid diethyl ester and (3-chloropropyl) triethoxysilane in anhydrous DMF, and stirring for 2h at 60 ℃.
7. The method according to claim 1, wherein, in the step 1),
the volume ratio of triethylene glycol to allyl bromide is preferably 1mL:1.5mL;
the mass-to-volume ratio of the sodium lumps to the triethylene glycol is preferably 1g:2.8mL;
the volume ratio of THF to triethylene glycol is preferably 3mL:1mL.
8. The method according to claim 1, wherein in step/2),
the mass ratio of ethyl iodoacetate to TG-aly is preferably 1g:2.5g;
the volume-to-mass ratio of DMF to iodoethyl acetate is preferably 1mL:0.05g;
the volume mass ratio of DBU to allyloxytrimethylene glycol is preferably 1 μ L:1.25g.
9. The method according to claim 1, wherein, in the step 3),
the mass ratio of allyloxytrimethyleneglycol acyliminodiacetic acid diethyl ester to MCPBA is preferably 1g:1g of a compound;
allyloxytrimethyleneglycol acyliminodiacetic acid diethyl ester with Ph 3 The mass ratio of P is preferably 1g:2g of the total weight of the composition.
10. The method according to claim 1, wherein, in the step 4),
the volume ratio of DMF to diethyl epoxypropyltriglycol acyliminodiacetate is preferably 4mL:3mL;
the volume-to-mass ratio of (3-chloropropyl) triethoxysilane to TEBA is preferably 1mL:0.2g.
CN202211289012.1A 2022-10-20 2022-10-20 Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane Pending CN115572306A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211289012.1A CN115572306A (en) 2022-10-20 2022-10-20 Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211289012.1A CN115572306A (en) 2022-10-20 2022-10-20 Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane

Publications (1)

Publication Number Publication Date
CN115572306A true CN115572306A (en) 2023-01-06

Family

ID=84586676

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211289012.1A Pending CN115572306A (en) 2022-10-20 2022-10-20 Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane

Country Status (1)

Country Link
CN (1) CN115572306A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540549A (en) * 2019-10-10 2019-12-06 山东大学 A kind of coumarin-based bridged silane and its preparation method
CN112047974A (en) * 2020-09-09 2020-12-08 山东大学 Photodegradable bridged silane and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540549A (en) * 2019-10-10 2019-12-06 山东大学 A kind of coumarin-based bridged silane and its preparation method
CN112047974A (en) * 2020-09-09 2020-12-08 山东大学 Photodegradable bridged silane and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101066971A (en) Non-enantioselective prepn process of emtricitabine
CN110776528A (en) Ammonium sulfonate zwitterionic silane coupling agent, siloxane ring body and preparation method thereof
CN112812107B (en) Preparation method of SGLT-2 inhibitor and intermediate
CN113061111A (en) Method for preparing amino acid compound with photocrosslinking activity
CN1137887C (en) A kind of improved method of synthesizing valsartan
CN115947759A (en) Preparation method of medicine Ruidexiwei for treating new coronary disease
CN115572306A (en) Synthesis method of novel silane coupling agent trioxy-triethoxy-iminodiacetic acid diethyl ester organosilane
CN109476687B (en) Preparation method of chiral phosphate
CN111170893B (en) Lefamulin intermediate compound and application thereof in preparation of Lefamulin
CN109748787B (en) A kind of method for preparing artemisinic acid
CN110872317A (en) A kind of preparation method of antitumor drug molecule (+)-Preussin intermediate
CN104402852A (en) Method for synthesizing natural product Tarchonanthuslactone isomer
CN116333027A (en) Preparation method of high-yield glycocholic acid
CN106632160A (en) Methods for preparing semi-synthetic paclitaxel and intermediate thereof
CN115819288B (en) Nitrile oxide, difunctional nitrile oxide and preparation method thereof
CN112778189A (en) (3R,4S) -N-substituent-3-carboxylic acid-4-ethyl pyrrolidine, intermediate and lapatinib
CN1308289C (en) Synthesis method for water-soluble bisamide oxide
CN101709047A (en) Chemical complete synthesis method for 22nd natural amino acid-pyrrolysine
CN111303172A (en) Method for preparing etodolac methyl ester
CN115466191B (en) A method for preparing dendrimers in a continuous flow
JPS61205277A (en) Novel epoxy compound
JPS62283982A (en) Production of bis((alkoxysilyl)alkyl)disulfide
CN105131026B (en) A kind of dual-component catalyst synthesizes N, the method for O-bis- (trimethylsilyl) acetamide
JP4200418B2 (en) Silanols and intermediates thereof, method for producing the same, and method for producing alcohols
CN102140124A (en) Novel synthesis process of capecitabine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20230106

WD01 Invention patent application deemed withdrawn after publication